Growth rate-driven modelling suggests that phenotypic adaptation drives drug resistance in BRAFV600E-mutant melanoma
Sara Hamis, Alexander P. Browning, Adrianne L. Jenner…·Tyler Cassidy
The paper develops a model to show phenotypic adaptation drives drug resistance in BRAFV600E-mutant melanoma and suggests intermittent treatments may be more effective.